AnaptysBio Inc. (ANAB) |
|
74.7 1.37 (1.87%)
|
05-24 16:00 |
|
Open: |
73.83 |
Pre. Close: |
73.33 |
|
High:
|
75.54 |
Low:
|
73.43 |
|
Volume:
|
177,216 |
Market Cap:
|
2019M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
75.548 - 75.811 |
75.811 - 76.051 |
|
Low:
|
72.674 - 73.012 |
73.012 - 73.322 |
|
Close:
|
74.162 - 74.635 |
74.635 - 75.068 |
|
|
|
Technical analysis |
as of: 2019-05-26 10:09:02 PM |
|
Overall:
|
 |
| Stoxline posted a STRONG BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 90.95 One year: 106.23 |
| Support: |
Support1: 72.10 Support2: 68.53 |
| Resistance: |
Resistance1: 77.87 Resistance2: 90.95 |
| Pivot: |
72.11  |
| Moving Average: |
MA(5): 71.72 MA(20): 72.32 
MA(100): 71.15 MA(250): 75.27 |
| MACD: |
MACD(12,26): -0.41 Signal(9): -0.63 |
| Stochastic oscillator: |
%K(14,3): 63.80 %D(3): 43.96 |
| RSI: |
RSI(14): 54.48 |
| 52-week: |
High: 110.00 Low: 54.26 Change(%): -4.1 |
| Average Vol(K): |
3-Month: 24637 10-Days: 23697 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.ANAB has closed below upper band by 12.6%. Bollinger Bands are 43.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to ANAB's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Mon, 20 May 2019 13:07:10 Z
Peek Under The Hood: VB Has 14% Upside
Wed, 08 May 2019 21:58:23 Z
AnaptysBio Started 2019 Quiet as a Ninja
Wed, 17 Apr 2019 15:14:32 Z
What Makes AnaptysBio, Inc. (ANAB) a New Strong Buy Stock
Thu, 04 Apr 2019 12:09:41 Z
Will AnaptysBio Continue to Surge Higher?
Thu, 21 Mar 2019 17:08:28 Z
Commit To Buy AnaptysBio At $55, Earn 14.4% Annualized Using Options
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
27.02 |
| Shares Float (M) |
26.59 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-2.500 |
|
EPS Est. Current Year
|
-1.990 |
|
EPS Est. Next Year
|
-3.060 |
|
EPS Est. Next Quarter
|
-0.660 |
|
Forward EPS
|
-3.290 |
|
Book Value (p.s.)
|
4.230 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-1514.74 |
|
Return on Assets (ttm)
|
-17.0 |
|
Return on Equity (ttm)
|
-18.0 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-52.13 |
|
Levered Free Cash Flow (M)
|
-30.22 |
Stock Valuations |
|
P/E
|
-29.88 |
|
P/E Growth Ratio
|
0.02 |
|
P/BV
|
17.66 |
|
P/S
|
10091969536.00 |
|
P/CF
|
-38.72 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
